Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Proposed changes to the Medical Devices Regulations to address future public health...

Health Canada is proposing regulatory amendments to the Medical Devices Regulations (MDR). We're proposing to expand the current provisions under Part 1.1 of the MDR, currently...

USA – TCET pathway may broaden access to breakthrough devices, but reforms still needed

While the Transitional Coverage for Emerging Technologies (TCET) pathway proposed by the Centers for Medicare and Medicaid Services (CMS) offers the potential to speed...

USA – FDA premarket cybersecurity guidance clarifies SBOM requirements

The US Food and Drug Administration (FDA) has published a premarket cybersecurity guidance almost a decade in the making. The document adds requirements based...

USA – MedCon: Consider the device risk management file a ‘living document’

Device manufacturers need to keep their risk documentation up to date throughout the total product life cycle by monitoring production and post-production information, according...

USA – FDA draft guidance covers low-level light therapy devices

The US Food and Drug Administration (FDA) has published a draft guidance for low-level light therapy (LLLT) devices, or photobiomodulation (PBM) devices, which are...

USA – Use of International Standard ISO 10993-1, « Biological evaluation of medical devices –...

FDA has developed this guidance document to assist industry in preparing Premarket Applications (PMAs), Humanitarian Device Exceptions (HDEs), Investigational Device Applications (IDEs), Premarket Notifications...
Institutional Review Board (IRB) submissions: Necessary for usability tests?

USA – New US FDA Guidance on Human Factors Engineering for Medical Devices

The US Food and Drug Administration has issued a new draft human factors engineering (HFE) guidance this week titled: Content of Human Factors Information in...

USA – EPA proposes rules on EtO with implications for medical device sterilization

The US Environmental Protection Agency (EPA) has proposed two much-anticipated rules that would restrict how much ethylene oxide (also referred to as EO or...

USA – FDA proposes breakthrough status for devices that address health disparities

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has proposed that devices that aim to eliminate disparities in...
Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance

USA – FDA finalizes which clinical decision software functions it regulates

The US Food and Drug Administration (FDA) announced that it has finalized guidance on which clinical decision software (CDS) functions it regulates as a...

NOS PROCHAINES FORMATIONS